Status:
UNKNOWN
Lymphadenectomy in NSCLC With and Without Adjuvant Therapy
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
NSCLC
Lymph Node Metastases
Eligibility:
All Genders
18+ years
Brief Summary
Adjuvant therapy in patients affected by NSCLC is indicated in surgically treated cases of N2 disease, while the actual guidelines reported the possibility of a case-by-case decision in case of N1 inv...
Eligibility Criteria
Inclusion
- Informed consent
- Age \>18 years
- Non-Small Cell Lung Cancer Histology
- Anatomical lung resection (segmentectomy, lobectomy or bilobectomy, pneumonectomy)
- Pre-operative CT and PET evaluation
- Preoperative and postoperative tumour board discussion
- Intraoperative lymph node assessment (minimum 3 mediastinal stations harvested)
- Lymph node metastases
Exclusion
- AGE \< 18 years
- Pregnancy
- Psychiatric disease
- Wedge resection
- Distant metastases
Key Trial Info
Start Date :
May 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04419935
Start Date
May 13 2020
End Date
May 1 2025
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marco Chiappetta
Roma, Italy, 00168